Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$153,928,136
+$72,394,626 QoQ
Shares Held
1,471,307
+106.0% QoQ
Ownership
3.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#10
of 274 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,375,424 across 337 Biotechnology names. CELC ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CELC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,666,114 | 3,170,198 | Shares | Sole | 2026-08-11 | |
| 2026-06-30 | $153,928,136 | 1,471,307 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $81,533,510 | 714,329 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $97,457,745 | 977,118 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,652,631 | 539,527 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,509,367 | 262,874 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,544,979 | 251,729 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,773,309 | 288,259 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,135,317 | 277,352 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,777,145 | 230,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,194,886 | 240,504 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $286,809 | 19,685 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $200,850 | 21,975 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $136,228 | 12,407 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $77,151 | 7,527 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $44,257 | 3,159 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $22,610 | 2,252 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $63 | 7 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,710 | 4,568 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $73,916 | 5,604 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $42,570 | 2,365 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,280 | 1,720 | Shares | Defined | 2021-09-13 | |
| 2020-09-30 | $220 | 38 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $144 | 21 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,600 | 1,477 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||